Goodwin

Sarah Bock

Deals
4
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 4 deals
Deals by year
Sarah Bock: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Sarah Bock was named on, most recent first
Jun 2026 Alloy Enterprises –Johnson ControlsAcquisitionLegal adviser to Alloy Enterprises (target)Announced–Manufacturing+2Johnson Controls acquisition of Alloy Enterprises
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Kelonia Therapeutics (target)Announced7,000.0Biotech+2Eli Lilly and Company acquisition of Kelonia Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Orna Therapeutics (target)Announced2,400.0Biotech+1Eli Lilly and Company acquisition of Orna Therapeutics

Deals where Sarah Bock is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.